Genetic and Covalent Protein Modification Strategies to Facilitate Intracellular Delivery

• Published in: Biomacromolecules Vol. 22; no. 12; pp. 4883 - 4904
• Main Authors: Horn, Justin M, Obermeyer, Allie C
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 13-12-2021
• Subjects: Cell-Penetrating Peptides - metabolism; Cell-Penetrating Peptides - pharmacology; Cytosol - metabolism; Endocytosis; Endosomes - metabolism; Molecular Targeted Therapy - methods; Peptides - metabolism; Proteins - metabolism
• ISSN: 1525-7797; 1526-4602
• DOI: 10.1021/acs.biomac.1c00745

Protein-based therapeutics represent a rapidly growing segment of approved disease treatments. Successful intracellular delivery of proteins is an important precondition for expanded in vivo and in vitro applications of protein therapeutics. Direct modification of proteins and peptides for improved cytosolic translocation are a promising method of increasing delivery efficiency and expanding the viability of intracellular protein therapeutics. In this Review, we present recent advances in both synthetic and genetic protein modifications for intracellular delivery. Active endocytosis-based and passive internalization pathways are discussed, followed by a review of modification methods for improved cytosolic delivery. After establishing how proteins can be modified, general strategies for facilitating intracellular delivery, such as chemical supercharging or inclusion of cell-penetrating motifs, are covered. We then outline protein modifications that promote endosomal escape. We finally examine the delivery of two potential classes of therapeutic proteins, antibodies and associated antibody fragments, and gene editing proteins, such as cas9.